LITS
Lite·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
LITS Profile
Lite Strategy, Inc.
A company established in2018,originally focused on business consulting,has now transformed into a digital asset vault management company specializing in Litecoin reserves
9920 Pacific Heights Blvd., Suite 150, San Diego, CA 92121
--
Lite Strategy, Inc., is a clinical-stage pharmaceutical company dedicated to the development of new and differentiated cancer therapies. The company builds its pipeline by acquiring promising cancer drugs and creates value in projects through clinical development, strategic partnerships, and outsourcing licensing or commercialization, as the case may be. Their pipeline of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3Kδ inhibitor, a preclinical drug candidate.
